Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|June 1, 2005
Biologic effects and basic science of a novel immune-modulation therapyAnthony E Bolton
Neuroimmunomodulation|March 24, 2005
Evidence of an anti-inflammatory role for Vasogen's immune modulation therapyYvonne Nolan, Veronica A Campbell, Anthony E Bolton, et al.
Behavioural Brain Research|September 27, 2008
Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's diseasePatrick Fitzgerald, Arkady Mandel, Anthony E Bolton, et al.
Neuroimmunomodulation|September 11, 2002
Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation TherapyYvonne Nolan, Aedín Minogue, Emily Vereker, et al.
Experimental Gerontology|January 6, 2009
The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025Anne-Marie Miller, Alessia Piazza, Darren S D Martin, et al.
Neuroimmunomodulation|July 18, 2009
A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the ratDarren S D Martin, Michelle Walsh, Anne-Marie Miller, et al.
The Journal of Biological Chemistry|December 24, 2004
Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampusYvonne Nolan, Frank O Maher, Darren S Martin, et al.
Reproduction & Fertility|August 5, 2022
Resurrecting biodiversity: advanced assisted reproductive technologies and biobankingRhiannon L Bolton, Andrew Mooney, Matt T Pettit, et al.
Transplantation|November 27, 2002
Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapyJohanne Tremblay, Huifang Chen, Junzheng Peng, et al.
Pageof 1